CD8A and neoplasm: CDNs increased tumor-specific CD8+ T cells infiltration and potentiated the therapeutic efficacy of anti-CTLA-4, anti-PD-1, and anti-4-1BB, and reprogrammed suppressive tumor-associated macrophages to a proinflammatory phenotype, namely M1 macrophage 49.